SuzanneLouiseTopalianMD
General Surgery • Baltimore, MDSurgical Oncology (Other than Breast)
Professor of Surgery, Professor of Oncology, Johns Hopkins University School of Medicine; Melanoma Program Director
Are you Dr. Topalian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 60 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-6796Fax+1 410-502-1958- Is this information wrong?
Summary
- Dr. Suzanne Topalian, MD is a general surgeon in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and Pennsylvania. She is affiliated with Johns Hopkins Howard County Medical Center and is a Professor of Surgery at Johns Hopkins University School of Medicine; Melanoma Program Director.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1987 - 1989- Clinical Center at the National Institutes of HealthResidency, Surgery, 1985 - 1986
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Surgery, 1983 - 1985
Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Surgery, 1982 - 1983- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Surgery, 1979 - 1982
Tufts University School of MedicineClass of 1979
Certifications & Licensure
MD State Medical License 2006 - 2025
PA State Medical License 1981 - 2014
Clinical Trials
- Vaccine Therapy in Treating Patients With Metastatic Melanoma Start of enrollment: 1999 Jul 01
- Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma Start of enrollment: 2003 Jan 01
Publications & Presentations
PubMed
- Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade.Shuming Chen, Tracee L McMiller, Abha Soni, Farah Succaria, John-William Sidhom, Laura C Cappelli, Livia A Casciola-Rosen, Isaac R Morales, Preethi Sankaran, Alan E Be...> ;Journal of Translational Medicine. 2024 Mar 5
- 1 citationsCirculating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma.Pulliam, T., Jani, S., Jing, L., Ryu, H., Jojic, A., Shasha, C., Zhang, J., Kulikauskas, R., Church, C., Garnett-Benson, C., Gooley, T., Chapuis, A., Paulson, K., Smit...> ;Cell Reports. Medicine. 2024 Feb 20
- 18 citationsNeoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy.Suzanne L Topalian, Patrick M Forde, Leisha A Emens, Mark Yarchoan, Kellie N Smith, Drew M Pardoll> ;Cancer Cell. 2023 Sep 11
- Join now to see all
Press Mentions
Tip Sheet: Johns Hopkins Kimmel Cancer Center Researchers to Present at Asco Annual MeetingMay 26th, 2023- Hopkins Immunotherapy Researchers Named Fellows of the SITC Academy of Immuno-OncologySeptember 19th, 2022
- Dragonfly Therapeutics Expands Leadership Team with Chief Operating Officer and Also Strengthens Scientific Advisory BoardNovember 24th, 2020
- Join now to see all
Grant Support
- Recognition Of Self And Mutated Self By Autoimmune And Tumor-Specific TcrsNational Institute Of Allergy And Infectious Diseases2010–2011
- B7-H1/Pd-1 Modulation In Cancer TherapyNational Cancer Institute2010–2011
- Recognition Of Self And Mutated Self By Autoimmune And Tumor-Specific TcrsNational Institute Of Allergy And Infectious Diseases2008–2009
Other Languages
- French
Hospital Affiliations
Johns Hopkins Howard County Medical CenterColumbia, Maryland
